 |
15 Diseases |  |
7 Trials |
|
7 Trials |  |
200 News |  |
| «1234» |
- |||||| Menopur (menotropin) / Ferring
Enrollment open: CLARA: Comparison of MENOPUR Liquid and Powder in Women Undergoing Assisted Reproductive Technology (ART) (clinicaltrials.gov) - Jul 13, 2020
P3, N=400, Recruiting, Sponsor: Ferring Pharmaceuticals
Suspended --> Recruiting
- | menotropin / Generic mfg.
Enrollment change: FSH Followed by HMG vs FSH Plus HMG in IVF (clinicaltrials.gov) - Jun 8, 2020
P4, N=530, Recruiting, Sponsor: Mansoura University
Suspended --> Recruiting N=280 --> 530
- | menotropin / Generic mfg.
Enrollment open: FSH Followed by HMG vs FSH Plus HMG in IVF (clinicaltrials.gov) - Jun 3, 2020
P4, N=280, Recruiting, Sponsor: Mansoura University
N=280 --> 530 Not yet recruiting --> Recruiting
- | Menopur (menotropin) / Ferring, Elonva (corifollitropin alfa) / Organon
New trial: Corifollitropin Alpha and Ovarian Response (clinicaltrials.gov) - Jun 3, 2020
P=N/A, N=300, Completed, Sponsor: Hospital de Clinicas de Porto Alegre
- | menotropin / Generic mfg.
New P4 trial: FSH Followed by HMG vs FSH Plus HMG in IVF (clinicaltrials.gov) - May 11, 2020
P4, N=280, Not yet recruiting, Sponsor: Mansoura University
- | Menopur (menotropin) / Ferring, NN1213 / Novo Nordisk
Trial completion date, Trial primary completion date: HRT Versus MOS for Endometrial Preparation Prior to FET in Non PCOS Patients (clinicaltrials.gov) - Apr 28, 2020
P4, N=150, Recruiting, Sponsor: Mansoura University
Not yet recruiting --> Recruiting Trial completion date: Mar 2020 --> Mar 2021 | Trial primary completion date: Jan 2020 --> Jan 2021
- ||||||||| Menopur (menotropin) / Ferring
Trial suspension: CLARA: Comparison of MENOPUR Liquid and Powder in Women Undergoing Assisted Reproductive Technology (ART) (clinicaltrials.gov) - Mar 24, 2020
P3, N=400, Suspended, Sponsor: Ferring Pharmaceuticals
Trial completion date: Mar 2020 --> Mar 2021 | Trial primary completion date: Jan 2020 --> Jan 2021 Recruiting --> Suspended
- Menopur (menotropin) / Ferring
[VIRTUAL] ADJUSTED INDIRECT COMPARISON OF THE MEDICINES USING IN CONTROLLED OVARIAN STIMULATION FOR ASSISTED REPRODUCTIVE TECHNOLOGY () - Mar 8, 2020 - Abstract #ISPOR2020ISPOR_1906;
CONCLUSIONS : AIC showed the absence of a statistically significant difference in the efficacy between menotropin and follitropin-alpha + menotropin. Due to the limitations of indirect comparison methodology additional direct study are required.
- | Trial completion date, Trial primary completion date: Human Growth Hormone Pre-treatment for 6 Weeks Prior to Ovulation Induction for IVF (clinicaltrials.gov) - Feb 18, 2020
P1/2, N=30, Enrolling by invitation, Sponsor: Center for Human Reproduction
Due to the limitations of indirect comparison methodology additional direct study are required. Trial completion date: Jun 2019 --> Jun 2022 | Trial primary completion date: Jun 2018 --> Jun 2021
- | Menopur (menotropin) / Ferring
Retrospective data, Journal: Efficacy of follicle-stimulating hormone as a treatment of severe idiopathic oligospermia: A retrospective study. (Pubmed Central) - Feb 6, 2020
The mean total motility in Group 1 was 20.3%, while Group 2 mean total motility was 27.5%. In conclusion, our study elicited that a dose of FSH as low as 75 IU can improve sperm count significantly in patients with severe IO.
- | Menopur (menotropin) / Ferring
Journal: Aberrant endometrial steroid receptor expression in in-vitro maturation cycles despite hormonal luteal support: A pilot study. (Pubmed Central) - Jan 23, 2020
Instead of being downregulated, both PR-B and ERĪ± in endometrial glands and stroma were moderately to strongly expressed in all three protocols, suggesting that the mid-luteal histological signature of endometrial receptivity is deficient in a non-hCG-triggered IVM cycle. Poor clinical outcomes after fresh embryo transfer following IVM are probably related to inappropriate endometrial development which may be linked to the short follicular phase of IVM cycles.
- || Menopur (menotropin) / Ferring, Follistim AQ Cartridge (follitropin beta) / Organon, Bravelle (urofollitropin) / Ferring
Biomarker, Trial completion date, Trial primary completion date, Adverse events: HEART: Hormone Evaluation in Artificial Reproductive Technology (clinicaltrials.gov) - Jan 22, 2020
P4, N=890, Recruiting, Sponsor: Lund University
Poor clinical outcomes after fresh embryo transfer following IVM are probably related to inappropriate endometrial development which may be linked to the short follicular phase of IVM cycles. Trial completion date: Dec 2020 --> Dec 2021 | Trial primary completion date: Jun 2020 --> Jun 2021
- metformin / Generic mfg.
Clinical twin pregnancy reported after delayed ICSI 24 hours post oocyte retrieval () - Jan 16, 2020 - Abstract #Fertility2020FERTILITY_257;
Delayed ICSI reportedly achieves poorer outcomes. However, performing delayed ICSI could give specific patients opportunity for a successful outcome where they would otherwise have a cancelled cycle.
- |||||||||| Menopur (menotropin) / Ferring
New P3 trial: CLARA: Comparison of MENOPUR Liquid and Powder in Women Undergoing Assisted Reproductive Technology (ART) (clinicaltrials.gov) - Nov 14, 2019
P3, N=400, Recruiting, Sponsor: Ferring Pharmaceuticals
- | Menopur (menotropin) / Ferring, NN1213 / Novo Nordisk
Trial completion date, Trial primary completion date: HRT Versus MOS for Endometrial Preparation Prior to FET in Non PCOS Patients (clinicaltrials.gov) - Oct 4, 2019
P4, N=150, Recruiting, Sponsor: Mansoura University
However, performing delayed ICSI could give specific patients opportunity for a successful outcome where they would otherwise have a cancelled cycle. Trial completion date: Oct 2019 --> Mar 2020 | Trial primary completion date: Aug 2019 --> Jan 2020
- | Menopur (menotropin) / Ferring, NN1213 / Novo Nordisk
Enrollment open, Trial completion date, Trial primary completion date: Predictors of Ovarian Reserve in Infertile Women (clinicaltrials.gov) - Sep 23, 2019
P4, N=100, Recruiting, Sponsor: Cairo University
Trial completion date: Oct 2019 --> Mar 2020 | Trial primary completion date: Aug 2019 --> Jan 2020 Not yet recruiting --> Recruiting | Trial completion date: Aug 2017 --> Mar 2020 | Trial primary completion date: Aug 2017 --> Jan 2020
- | Menopur (menotropin) / Ferring
Journal: Identification of the first homozygous POLG mutation causing non-syndromic ovarian dysfunction. (Pubmed Central) - Sep 11, 2019
This study has improved our understanding of POLG-related genetic mutations in ovarian dysfunction, and the mode of inheritance of certain sequence variants. This information will assist genetic counseling and precision medicine in the future.
- | Rekovelle (follitropin delta) / Ferring, Menopur (menotropin) / Ferring
Trial completion: MARCS: Menopur And Rekovelle Combination Study (clinicaltrials.gov) - Aug 28, 2019
P=N/A, N=160, Completed, Sponsor: Dr Fran
This information will assist genetic counseling and precision medicine in the future. Recruiting --> Completed
- | Ovidrel (choriogonadotropin alfa) / EMD Serono, Menopur (menotropin) / Ferring, Cetrotide (cetrorelix) / EMD Serono
New trial: CS-EOSP-ICSI: Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female Infertility (clinicaltrials.gov) - Aug 28, 2019
P=N/A, N=200, Recruiting, Sponsor: Lebanese University
- | Menopur (menotropin) / Ferring, Orgalutran (ganirelix acetate) / Organon, Cetrotide (cetrorelix) / EMD Serono
Trial completion date, Trial primary completion date: DuoStim in Cases of PGT: Comparison of Embryo Quantity and Embryonic Quality Using MitoScore (clinicaltrials.gov) - Aug 19, 2019
P=N/A, N=136, Recruiting, Sponsor: IVI Madrid
Recruiting --> Completed Trial primary completion date: Oct 2018 --> Dec 2019 | Trial completion date: Dec 2018 --> Jun 2020
- ||| Menopur (menotropin) / Ferring
Trial completion, Enrollment change: A Study on Efficacy and Safety of Menopur (clinicaltrials.gov) - Mar 28, 2019
P=N/A, N=412, Completed, Sponsor: Ferring Pharmaceuticals
Trial primary completion date: Oct 2018 --> Dec 2019 | Trial completion date: Dec 2018 --> Jun 2020 Recruiting --> Completed | N=2002 --> 412
- ||| Menopur (menotropin) / Ferring
Trial completion, Trial completion date: A Study to Measure Relationship Between Antim (clinicaltrials.gov) - Mar 5, 2019
P=N/A, N=297, Completed, Sponsor: Ferring Pharmaceuticals
Recruiting --> Completed | N=2002 --> 412 Active, not recruiting --> Completed | Trial completion date: Jan 2019 --> Jun 2018
- | Rekovelle (follitropin delta) / Ferring, Menopur (menotropin) / Ferring
Trial completion date, Trial primary completion date: MARCS: Menopur And Rekovelle Combination Study (clinicaltrials.gov) - Jan 31, 2019
P=N/A, N=160, Recruiting, Sponsor: Dr Fran
Active, not recruiting --> Completed | Trial completion date: Jan 2019 --> Jun 2018 Trial completion date: Dec 2018 --> May 2019 | Trial primary completion date: Dec 2018 --> May 2019
- | Menopur (menotropin) / Ferring, Follistim AQ Cartridge (follitropin beta) / Organon, Bravelle (urofollitropin) / Ferring
Biomarker, New P4 trial, Adverse events: HEART: Hormone Evaluation in Artificial Reproductive Technology (clinicaltrials.gov) - Nov 9, 2018
P4, N=890, Recruiting, Sponsor: Lund University
- | Menopur (menotropin) / Ferring, NN1213 / Novo Nordisk
Trial completion, Phase classification, Trial completion date, Trial primary completion date: HRT Versus MOS for Endometrial Preparation Prior to FET in PCOS Patients (clinicaltrials.gov) - Oct 29, 2018
P=N/A, N=126, Completed, Sponsor: Mansoura University
Trial completion date: Dec 2018 --> May 2019 | Trial primary completion date: Dec 2018 --> May 2019 Recruiting --> Completed | Phase classification: P4 --> PN/A | Trial completion date: Jan 2018 --> Apr 2016 | Trial primary completion date: Nov 2017 --> Mar 2016
- | Menopur (menotropin) / Ferring, NN1213 / Novo Nordisk
Trial completion date, Trial primary completion date: HRT Versus MOS for Endometrial Preparation Prior to FET in Non PCOS Patients (clinicaltrials.gov) - Oct 26, 2018
P4, N=150, Recruiting, Sponsor: Mansoura University
Recruiting --> Completed | Phase classification: P4 --> PN/A | Trial completion date: Jan 2018 --> Apr 2016 | Trial primary completion date: Nov 2017 --> Mar 2016 Trial completion date: Oct 2018 --> Oct 2019 | Trial primary completion date: Aug 2018 --> Aug 2019
- | Rekovelle (follitropin delta) / Ferring, Menopur (menotropin) / Ferring
Enrollment open, Trial completion date, Trial primary completion date: MARCS: Menopur And Rekovelle Combination Study (clinicaltrials.gov) - Oct 1, 2018
P=N/A, N=160, Recruiting, Sponsor: Dr Fran
Trial completion date: Oct 2018 --> Oct 2019 | Trial primary completion date: Aug 2018 --> Aug 2019 Not yet recruiting --> Recruiting | Trial completion date: Sep 2018 --> Dec 2018 | Trial primary completion date: Aug 2018 --> Dec 2018
- | Menopur (menotropin) / Ferring, Orgalutran (ganirelix acetate) / Organon, Cetrotide (cetrorelix) / EMD Serono
Trial completion date, Trial primary completion date: DuoStim in Cases of PGT: Comparison of Embryo Quantity and Embryonic Quality Using MitoScore (clinicaltrials.gov) - Sep 4, 2018
P=N/A, N=136, Recruiting, Sponsor: IVI Madrid
Not yet recruiting --> Recruiting | Trial completion date: Sep 2018 --> Dec 2018 | Trial primary completion date: Aug 2018 --> Dec 2018 Trial completion date: Aug 2018 --> Dec 2018 | Trial primary completion date: Jun 2018 --> Oct 2018
- | Menopur (menotropin) / Ferring
Trial completion date: A Study to Measure Relationship Between Antim (clinicaltrials.gov) - Aug 7, 2018
P=N/A, N=296, Active, not recruiting, Sponsor: Ferring Pharmaceuticals
Trial completion date: Aug 2018 --> Dec 2018 | Trial primary completion date: Jun 2018 --> Oct 2018 Trial completion date: Jul 2018 --> Jan 2019
- | Rekovelle (follitropin delta) / Ferring, Menopur (menotropin) / Ferring
Trial initiation date: MARCS: Menopur And Rekovelle Combination Study (clinicaltrials.gov) - Jul 16, 2018
P=N/A, N=160, Not yet recruiting, Sponsor: Dr Fran
Trial completion date: Jul 2018 --> Jan 2019 Initiation date: May 2018 --> Aug 2018
- | Menopur (menotropin) / Ferring
Trial completion, Enrollment change: AMH and Dosing Regimens for Initial IVF Stimulation Protocols (clinicaltrials.gov) - Apr 12, 2018
P=N/A, N=78, Completed, Sponsor: Reproductive Specialists of New York
Initiation date: May 2018 --> Aug 2018 Enrolling by invitation --> Completed | N=170 --> 78
- | Rekovelle (follitropin delta) / Ferring, Menopur (menotropin) / Ferring
New trial: MARCS: Menopur And Rekovelle Combination Study (clinicaltrials.gov) - Mar 30, 2018
P=N/A, N=160, Not yet recruiting, Sponsor: Dr Fran
- || Menopur (menotropin) / Ferring
Enrollment closed: A Study to Measure Relationship Between Antim (clinicaltrials.gov) - Mar 15, 2018
P=N/A, N=296, Active, not recruiting, Sponsor: Ferring Pharmaceuticals
Enrolling by invitation --> Completed | N=170 --> 78 Recruiting --> Active, not recruiting
- || Menopur (menotropin) / Ferring
Trial primary completion date: A Study to Measure Relationship Between Antim (clinicaltrials.gov) - Mar 3, 2018
P=N/A, N=340, Recruiting, Sponsor: Ferring Pharmaceuticals
Recruiting --> Active, not recruiting Trial primary completion date: Dec 2017 --> Jan 2018
- | Menopur (menotropin) / Ferring, Orgalutran (ganirelix acetate) / Organon, Cetrotide (cetrorelix) / EMD Serono
Enrollment open, Trial initiation date: DuoStim in Cases of PGT: Comparison of Embryo Quantity and Embryonic Quality Using MitoScore (clinicaltrials.gov) - Feb 28, 2018
P=N/A, N=136, Recruiting, Sponsor: IVI Madrid
Trial primary completion date: Dec 2017 --> Jan 2018 Not yet recruiting --> Recruiting | Initiation date: Sep 2017 --> Dec 2017
- | Menopur (menotropin) / Ferring, Follistim AQ Cartridge (follitropin beta) / Organon, Bravelle (urofollitropin) / Ferring
Enrollment change: Maximal Stimulation and Delayed Fertilization for Diminished Ovarian Reserve: a Randomized Pilot Study (clinicaltrials.gov) - Feb 23, 2018
P4, N=23, Completed, Sponsor: Carolinas Healthcare System
Not yet recruiting --> Recruiting | Initiation date: Sep 2017 --> Dec 2017 N=100 --> 23
- | Menopur (menotropin) / Ferring, Orgalutran (ganirelix acetate) / Organon, Follistim AQ Cartridge (follitropin beta) / Organon
Trial completion, Trial primary completion date: Efficacy of Recombinant FSH/GnRH Antagonist Protocol With and Without LH Adjunct for Egg Bank Donation (clinicaltrials.gov) - Feb 13, 2018
P4, N=39, Completed, Sponsor: Michigan Reproductive Medicine
N=100 --> 23 Recruiting --> Completed | Trial primary completion date: Apr 2018 --> Feb 2017
- | Menopur (menotropin) / Ferring
Trial primary completion date: HRT Versus MOS for Endometrial Preparation Prior to FET in Non PCOS Patients (clinicaltrials.gov) - Nov 29, 2017
P4, N=150, Recruiting, Sponsor: Mansoura University
Recruiting --> Completed | Trial primary completion date: Apr 2018 --> Feb 2017 Trial primary completion date: Aug 2017 --> Aug 2018
- | Menopur (menotropin) / Ferring
Trial primary completion date: HRT Versus MOS for Endometrial Preparation Prior to FET in PCOS Patients (clinicaltrials.gov) - Nov 28, 2017
P4, N=150, Recruiting, Sponsor: Mansoura University
Trial primary completion date: Aug 2017 --> Aug 2018 Trial primary completion date: Jun 2017 --> Nov 2017
- |||| Rekovelle (follitropin delta) / Ferring, Menopur (menotropin) / Ferring
Trial completion: MEGASET HR: MENOPUR (clinicaltrials.gov) - Oct 13, 2017
P4, N=620, Completed, Sponsor: Ferring Pharmaceuticals
Trial primary completion date: Jun 2017 --> Nov 2017 Active, not recruiting --> Completed
- | Menopur (menotropin) / Ferring, Orgalutran (ganirelix acetate) / Organon, Cetrotide (cetrorelix) / EMD Serono
New trial: DuoStim in Cases of PGT: Comparison of Embryo Quantity and Embryonic Quality Using MitoScore (clinicaltrials.gov) - Sep 24, 2017
P=N/A, N=136, Not yet recruiting, Sponsor: IVI Madrid
- ||| Menopur (menotropin) / Ferring
Trial completion, Trial primary completion date: An Explorative Prospective Observational Study to Describe Morphokinetic De-selection Parameters in Human Embryos (clinicaltrials.gov) - Aug 28, 2017
P=N/A, N=738, Completed, Sponsor: Ferring Pharmaceuticals
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Aug 2016 --> Feb 2016
- | Trial primary completion date: Human Growth Hormone Pre-treatment for 6 Weeks Prior to Ovulation Induction for IVF (clinicaltrials.gov) - Jul 12, 2017
P1/2, N=30, Enrolling by invitation, Sponsor: Center for Human Reproduction
Active, not recruiting --> Completed | Trial primary completion date: Aug 2016 --> Feb 2016 Trial primary completion date: Jun 2017 --> Jun 2018
- | Menopur (menotropin) / Ferring, Synarel (nafarelin) / Pfizer
Trial completion, Enrollment change, Trial primary completion date: Protocol to Minimize Injections and Blood Draws for Women Undergoing in Vitro Fertilization (clinicaltrials.gov) - Jun 9, 2017
P=N/A, N=4, Completed, Sponsor: New Hope Fertility Center
Trial primary completion date: Jun 2017 --> Jun 2018 Recruiting --> Completed | N=60 --> 4 | Trial primary completion date: Dec 2016 --> Jun 2017
- | Menopur (menotropin) / Ferring
Trial primary completion date: HRT Versus MOS for Endometrial Preparation Prior to FET in Non PCOS Patients (clinicaltrials.gov) - May 10, 2017
P4, N=150, Recruiting, Sponsor: Mansoura University
Recruiting --> Completed | N=60 --> 4 | Trial primary completion date: Dec 2016 --> Jun 2017 Trial primary completion date: Jan 2017 --> Aug 2017
- | Menopur (menotropin) / Ferring
Trial primary completion date: HRT Versus MOS for Endometrial Preparation Prior to FET in PCOS Patients (clinicaltrials.gov) - May 10, 2017
P4, N=150, Recruiting, Sponsor: Mansoura University
Trial primary completion date: Jan 2017 --> Aug 2017 Trial primary completion date: Jan 2017 --> Jun 2017
- | Menopur (menotropin) / Ferring
New trial: AMH and Dosing Regimens for Initial IVF Stimulation Protocols (clinicaltrials.gov) - Mar 31, 2017
P=N/A, N=170, Enrolling by invitation, Sponsor: Reproductive Specialists of New York
- | purified human menopausal gonadotropin / Generic mfg.
New P4 trial: Androgenic Profile Following Controlled Ovarian Stimulation (clinicaltrials.gov) - Dec 14, 2016
P4, N=100, Not yet recruiting, Sponsor: Sheba Medical Center
- Menopur (menotropin) / Ferring
New trial: Effects of SNP of GnRH Receptor Genes in IVF Patients (clinicaltrials.gov) - Dec 2, 2016
P=N/A, N=1500, Enrolling by invitation, Sponsor: Miao benyu
- Menopur (menotropin) / Ferring
Trial primary completion date: HRT Versus MOS for Endometrial Preparation Prior to FET in Non PCOS Patients (clinicaltrials.gov) - Nov 21, 2016
P4, N=150, Recruiting, Sponsor: Mansoura University
Trial primary completion date: Jan 2017 --> Jun 2017 Trial primary completion date: Sep 2016 --> Jan 2017